Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Colombo
Red Hat Certified System Administrator (RHCSA) - RHEL 10
Sanjeewani95
Updated:
Yesterday at 7:43 PM
NURSING , CAREGIVER , HOTEL & BEAUTY COURSES
IVA Para Medical Campus
Updated:
Thursday at 9:24 AM
Handmade Character Soft Toys Peppa Pig Family
anil1961
Updated:
Wednesday at 9:58 PM
Ad icon
Video Content Creator
pramukag
Updated:
Sunday at 6:10 AM
Ad icon
QA Engineer Intern
pramukag
Updated:
Sunday at 6:07 AM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
Recent study reveals new Spike conformations that could lead to many developments.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26653204" data-attributes="member: 562115"><p>A recently published paper states that -</p><p></p><p>"Current COVID-19 vaccines and many clinical diagnostics are based on the structure and function of the SARS-CoV-2 spike ectodomain. Using hydrogen deuterium exchange mass spectrometry, we have uncovered that, in addition to the prefusion structure determined by cryo-EM, this protein adopts an alternative conformation that interconverts slowly with the canonical prefusion structure. This new conformation—an open trimer— contains easily accessible RBDs. It exposes the conserved trimer interface buried in the prefusion conformation, thus exposing potential epitopes for pan-coronavirus antibody and ligand recognition....."</p><p></p><p>The above abstract doesn't provide much useful information to many....but,</p><p></p><p>Just in brief, a team from the University of California in Berkeley, the University of Texas at Austin, and Chan Zuckerberg Biohub in San Francisco have identified a new conformation exposing the conserved trimer interface that is otherwise buried in the prefusion state. This will lead to the opening up of <strong>potential new</strong> therapeutic targets.</p><p></p><p>Many would be aware that the Covid-19 Spike is a large trimeric protein that uses it's receptor-binding domain (RBD) to attach with the host cell ACE2 receptor. A stabilized version of the Spike ectodomain S2-P was widely used to develop the vaccines. Ectodomain usually refers to parts of proteins that make contact with surfaces - only after the attachment the entry into the host cell takes place. There are custom Protein Data Libraries where you can get these structures.</p><p>The RBDs have "up" & "down" conformations with the "up" allowing the ACE2 binding. After the binding and cleavage the Spike refolds allowing for prefusion, and subsequent post-fusion.</p><p></p><p>This team of researchers found that the spike protein populates <strong>two conformations within the prefusion state</strong> – with one particular state identified, will help to improve the development of diagnostics, therapeutics, and vaccines.</p><p>This state exposes broadly neutralization-sensitive epitopes that are in the <strong>most highly conserved part of the Spike</strong> – the <strong>S2 trimer</strong> interface – and therefore present an ideal target for vaccines that would provide protection across <strong>different</strong> <strong>coronaviruses</strong>.</p><p></p><p>PS: Let's hope someone will find a breakthrough that will lead to a drug or a vaccine that'll cover any variant of the coronavirus.</p></blockquote><p></p>
[QUOTE="imhotep, post: 26653204, member: 562115"] A recently published paper states that - "Current COVID-19 vaccines and many clinical diagnostics are based on the structure and function of the SARS-CoV-2 spike ectodomain. Using hydrogen deuterium exchange mass spectrometry, we have uncovered that, in addition to the prefusion structure determined by cryo-EM, this protein adopts an alternative conformation that interconverts slowly with the canonical prefusion structure. This new conformation—an open trimer— contains easily accessible RBDs. It exposes the conserved trimer interface buried in the prefusion conformation, thus exposing potential epitopes for pan-coronavirus antibody and ligand recognition....." The above abstract doesn't provide much useful information to many....but, Just in brief, a team from the University of California in Berkeley, the University of Texas at Austin, and Chan Zuckerberg Biohub in San Francisco have identified a new conformation exposing the conserved trimer interface that is otherwise buried in the prefusion state. This will lead to the opening up of [B]potential new[/B] therapeutic targets. Many would be aware that the Covid-19 Spike is a large trimeric protein that uses it's receptor-binding domain (RBD) to attach with the host cell ACE2 receptor. A stabilized version of the Spike ectodomain S2-P was widely used to develop the vaccines. Ectodomain usually refers to parts of proteins that make contact with surfaces - only after the attachment the entry into the host cell takes place. There are custom Protein Data Libraries where you can get these structures. The RBDs have "up" & "down" conformations with the "up" allowing the ACE2 binding. After the binding and cleavage the Spike refolds allowing for prefusion, and subsequent post-fusion. This team of researchers found that the spike protein populates [B]two conformations within the prefusion state[/B] – with one particular state identified, will help to improve the development of diagnostics, therapeutics, and vaccines. This state exposes broadly neutralization-sensitive epitopes that are in the [B]most highly conserved part of the Spike[/B] – the [B]S2 trimer[/B] interface – and therefore present an ideal target for vaccines that would provide protection across [B]different[/B] [B]coronaviruses[/B]. PS: Let's hope someone will find a breakthrough that will lead to a drug or a vaccine that'll cover any variant of the coronavirus. [/QUOTE]
Insert quotes…
Verification
Asuwa dahayen wadi kalama keeyada?
Post reply
Top
Bottom